Investigator's Brochure (IB) Table
Drugs
Drug Name | Drug Company | IB Date | Risk List Available? |
---|---|---|---|
Cenicriviroc Mesylate CVC (TBR-652) | Allergan | March 2020 | |
Tenofovir Alafenamide/Elvitegravir | CONRAD | July 2019 | |
Glecaprevir (ABT-493) and Pibrentasvir (ABT-530) | AbbVie | December 2018 | |
Cemiplimab (REGN2810) | Regeneron Pharmaceuticals, Inc. | June 2020 | |
Tenofovir Vaginal Ring | CONRAD | August 2017 | |
Sofosbuvir/Velapatasvir (Epclusa) | Gilead | July 2016 | |
PC-1005 | Population Council | April 2017 | |
Vorinostat (Zolinza) | Merck | August 2013 | |
GSK1265744 (Cabotegravir) | ViiV Healthcare | December 2019 | |
Maraviroc (UK-427857) | ViiV Healthcare | December 2020 | |
Raltegravir (Isentress) | Merck | September 2017 | YES |
Rifapentine | Sanofi | August 2013 | |
Rilpivirine (TMC278, Edurant) | Janssen Research & Development | July 2020 | |
Tenofovir Gel | CONRAD | January 2013 | |
ABT-267, ABT 333, ABT-450 and Ritonavir | AbbVie | June 2017 | |
Bedaquiline (TMC207) | Janssen Research & Development | October 2019 | |
Dapivirine (Microbicide Gel) | International Partnership for Microbicides | May 2017 | |
Dapivirine (Vaginal Ring) | International Partnership For Microbicides | November 2019 | |
Delamanid (OPC-67683) | Otsuka | April 2020 | |
Dolutegravir (GSK1349572) | ViiV Healthcare | September 2020 |
Vaccines
Vaccine Name | Vaccine Company Sort descending | IB Date | Risk List Available? |
---|---|---|---|
N-803 | Altor BioScience | April 2019 | |
PGT121 | Beth Israel Deaconess Medical Center | September 2020 | |
PGDM1400 | Beth Israel Deaconess Medical Center | August 2018 | |
Ad26.ENVA.01 | Crucell Holland BV | June 2013 | |
MPER-656 Liposomes with Aluminum Hydroxide Suspension | DAIDS/NIAID/NIH | February 2019 | |
BG505 SOSIP.664 gp140 | DAIDS/NIAID/NIH | October 2019 | |
DNA CON-S env | DAIDS/NIAID/NIH | June 2017 | |
DNA Mosaic-Tre env DNA Vaccine | DAIDS/NIAID/NIH | July 2016 | |
RV460 (ALF43) | DAIDS/NIAID/NIH | August 2020 | |
CH505 M5 gp120 | DAIDS/NIAID/NIH | February 2020 | |
EnvSeq-1 Vaccine (CH505TF gp120) | DAIDS/NIAID/NIH | February 2020 | |
CH505 TF chTrimer - New | DAIDS/NIAID/NIH | November 2020 | |
CH505TF gp120 Transient | DAIDS/NIAID/NIH | December 2018 | |
Hepatitis B Vaccine Recombinant, Adjuvanted (Heplisav-B) | Dynavax Technologies Corporation | August 2019 | |
GEO-D03 and MVA-HIV62B Vaccines (Preventative) | GeoVax | June 2013 | |
GEO-D02 and MVA-HIV62B Vaccine | GeoVax | June 2019 | |
Bivalent Subtype C gp120/AS01B | GlaxoSmithKline | July 2016 | |
Bivalent Subtype C gp120/MF59 | GlaxoSmithKline | July 2016 | |
AIDSVAX B/E | Global Solutions for Infectious Diseases | March 2016 | |
GLA-SE | Infectious Disease Research Institute (IDRI) | April 2019 |